---
$id: https://graph.org.ai/products/commodity/51112504
$type: Product
source: UNSPSC
code: "51112504"
title: "Bofumustine"
class: "51112500"
classTitle: "Alkylating agent nitrogen mustard compounds"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Bofumustine

**UNSPSC Code**: 51112504
**Class**: [Alkylating agent nitrogen mustard compounds](Alkylating agent nitrogen mustard compounds.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a nitrogen mustard compound with the molecular formula C18H21ClN4O9, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6P52D0J76B, chemically known as 1-(2-chloroethyl)-3-(2,3-o-isopropylidene-d-ribofuranosyl)-1-nitrosourea 5-(p-nitrobenzoate) but more generally known as bofumustine, which bears US NIH Compound Identifier 100269. European Medicines Agency schedules Bofumustine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05865MIG. The term BOFUMUSTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, No. 5 1981, List 21). BOFUMUSTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule bofumustine under HS 29329970 and SITC 51569. As of Q4 2014, BOFUMUSTINE remains US FDA's Preferred Term for this commodity. Bofumustine bears US NLM identifiers UMLS ID C2825244 and NCI Concept Code C80533. SMILES: CLCCN(N=O)C(=O)NC1OC(C2OC(OC12)(C)C)COC(=O)C1CCC([N](=O)O)CC1.

